✦ LIBER ✦

Risk of relapse and clinico-pathological features in 103 patients with diffuse large-cell lymphoma in complete response after first-line treatment

✍ Scribed by Llúcia Sanz; Armando López-Guillermo; Carmen Martínez; Francesc Bosch; Jordi Esteve; Francesc Cobo; Silvia Montoto; María Perales; Joan Bladé; Francisco Cervantes; Benet Nomdedeu; Elías Campo; Prof. Emilio Montserrat

Book ID: 114792415
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 531 KB
Volume: 61
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1998.tb01062.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphopenia following the completion of

Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma

✍ Tomohiro Aoki; Takahiro Nishiyama; Nobuhiko Imahashi; Kunio Kitamura 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 251 KB

Prognostic features and outcome in patie

Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens

✍ Luis Villela; Armando López-Guillermo; Silvia Montoto; Susana Rives; Francesc Bo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The lower peripheral blood lymphocyte/mo

The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

✍ Yan-Li, Li; Kang-Sheng, Gu; Yue-Yin, Pan; Yang, Jiao; Zhi-Min, Zhai 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 870 KB

Patients with diffuse large B cell lymph

Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation

✍ Man-Hsin Hung, Yuan-Bin Yu, Yu-Chung Huang, Han-Tsung Liu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 222 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB